[SD] ¼ 3.73 [95% confidence interval {CI}, À2.92 to
À0.78]).
Of the 140 developing countries, 26 reported improvements in YLDs from skin diseases, as indicated by a negative percent change from 1990 to 2013 (Fig 2) . The average percent change in developing countries was a 2.6% decrease in disability (SD ¼ 3.75 [95% CI, 2.04-3.29]). Ten countries saw no change, and the majority of developing countries (n ¼ 104) experienced an increase in disability. Nicaragua, Oman, and Palestine saw the greatest increase in percent change of disability (11%, 11%, and 15%, respectively).
Skin diseases continue to affect not only those living in developing countries, but also those living in developed countries. The decrease experienced in the United States was low (1%), especially when compared to other developed countries. In other words, the percentage of Americans living in less than ideal health because of skin diseases has not changed substantially in the past 23 years, even though the United States has been spending far more on health care than any other developed country. 4 An increase in life expectancy of Americans may partially account for a larger number of people living in the United States with skin diseases. Yet most of the developed countries have also experienced an increase in life expectancy. This therefore does not fully explain why the United States lags behind the majority of developed countries in terms of improvements in disability from skin disease. In addition, Americans may have higher expectations regarding treatment of skin diseases as a result of direct-to-consumer pharmaceutical advertising, which may overemphasize potential benefits of medications. 5 Patient expectations are unaccounted for in the IHME data.
Over the past 2 decades, the majority of both developed and developing countries have experienced little or no improvement in disability caused by skin diseases. Health care providers around the world must shift their focus to improving the quality of lives in their patients with skin diseases. 
